The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine
Steffan T. Nawrocki(University of Arizona), Jennifer S. Carew(University of Arizona), Mignon Keaton(University of Virginia), Mikkael A. Sekeres(University of Miami), Jaroslaw P. Maciejewski(Cleveland Clinic), Kevin R. Kelly(Keck Hospital of USC), Peter G. Smith(Ollscoil na Gaillimhe – University of Galway), Hetty E. Carraway(Cleveland Clinic)
Cited by 51
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k